BioMarck Pharmaceuticals Ltd — Form D/A

BioMarck Pharmaceuticals Ltd of DURHAM, NC, a company, filed a Form D amendment with the SEC on 2009-08-28. The offering totals $7.5M, of which $7.5M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
Thorsten U BeyerDirectorRaleigh, NC
Ron E DoggettDirectorRaleigh, NC
Allen F GantDirectorRaleigh, NC
Walker LongDirectorDurham, NC
Mark W MuellerDirectorRaleigh, NC
Kennedy C O'HerronDirectorRaleigh, NC
Indu ParikhDirectorDurham, NC
Thomas H RobergDirectorRaleigh, NC
Allen F GantExecutive OfficerRaleigh, NC
Mark W MuellerExecutive OfficerRaleigh, NC
Indu ParikhExecutive OfficerDurham, NC
Indu C ParikhExecutive OfficerDurham, NC
Craig A CollardDirectorDurham, NC
Rajin K AhujaDirectorDurham, NC
Laura Calamos NasirDirectorDurham, NC
Mohit K MehrotraDirectorDurham, NC
Walker Calamos LongDirectorDurham, NC
Brian DicksonExecutive OfficerDurham, NC
Ashish C BhatiaDirectorDurham, NC
Michael C EnrightExecutive OfficerDurham, NC
Robin C HenningExecutive OfficerDurham, NC
Thorsten U. BeyerDirectorDurham, NC
Allen F. GantDirectorDurham, NC
Ron E. DoggettDirectorDurham, NC
Kennedy H. O'HerronDirectorDurham, NC

Other filings by this issuer (3)

FiledFormOfferingSold
2017-02-08D$6.0M$751K
2016-05-18D$7.0M$7.0M
2012-08-09D$2.0M$266K

More